Chromosomal translocations leading to overexpression of p14TCL1 and its homologue p13 MTCP1 are hallmarks of several human T-cell malignancies (1). p14 TCL1 / p13 MTCP1 co-activate protein kinase B (PKB, also named Akt) by binding to its pleckstrin homology (PH) domain, suggesting that p14 TCL1 /p13 MTCP1 induce T-cell leukemia by promoting anti-apoptotic signals via PKB (2, 3). Here we combined fluorescence anisotropy, NMR, and small angle x-ray-scattering measurements to determine the affinities, molecular interfaces, and low resolution structure of the complex formed between PKB-PH and p14 TCL1 /p13 MTCP1 . We show that p14 TCL1 /p13 MTCP1 target PKB-PH at a site that has not yet been observed in PH-protein interactions. Located opposite the phospholipid binding pocket and distal from known proteinprotein interaction sites on PH domains, the binding of dimeric TCL1 proteins to this site would allow the crosslinking of two PKB molecules at the cellular membrane in a preactivated conformation without disrupting certain PH-ligand interactions. Thus this interaction could serve to strengthen membrane association, promote trans-phosphorylation, hinder deactivation of PKB, and involve PKB in a multi-protein complex, explaining the array of known effects of TCL1. The binding sites on both proteins present attractive drug targets against leukemia caused by TCL1 proteins.
Protein kinase B (PKB)1 is a 60-kDa member of the AGC superfamily of serine/threonine kinases composed of a aminoterminal PH domain and linked to a kinase domain by a 30 amino acid linker. PKB is frequently called Akt, because it is a mammalian homologue of v-Akt, a viral oncogene isolated from the Akt8 virus that causes T-cell leukemia in mice (4 -7). Actually, the PKB family comprises three members, PKB␣, PKB, and PKB␥ (Akt1, Akt2, and Akt3), all of which display, despite some idiosyncrasies, a high level of functional redundancy ( Fig. 1) (8). Protein kinase B is a central component of phosphoinositide 3Ј-kinase signaling pathways and has emerged as a pivotal regulator of many cellular processes including apoptosis, proliferation, differentiation, and metabolism (3, 9, 10). Deregulation of members of the PKB family has been associated with human pathologies such as cancer and diabetes (8).PKB activation in response to growth factors and other extracellular stimuli involves membrane recruitment of PKB triggered by inositol phospholipid (PtdIns-P) binding of its amino-terminal pleckstrin homology (PH) domain. At the membrane, PKB is activated by a partially defined process involving lipid-mediated dimerization and phosphorylation of two critical residues, The PH domain of PKB (PKB-PH) has been shown to be essential for mediating the targeting and co-activation of PKB by proteins of the T-cell leukemia-1 (TCL1) family (18,19). Normally, the cellular expression of TCL1 family genes (TCL1, TCL1b, and MTCP1) is mainly restricted to the lymphoid cell lineage and to the early stages of embryogenesis (20) where they co-activate PKB, possibly to promote a...